【Wuding Bio-Tech Co., Ltd.】Q1 2026 EPS 0.81 Yuan
Wuding Bio-Tech Co., Ltd. announced its Q1 2026 financial results, reporting an Earnings Per Share (EPS) of 0.81 yuan. The company achieved revenue of 520 million yuan and a net profit of 81 million yuan, reflecting solid operations in the biotechnology and healthcare sector.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (1727h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 08:39 (39 min after Collected)
Company Code: 1733
Company Name: Wuding Bio-Tech Co., Ltd.
Industry: Biotechnology and Healthcare
Year/Quarter: 2026 Q1
Basic Earnings Per Share: 0.81 Yuan
Operating Revenue: 520 million
Net Profit After Tax: 81 million
Keywords: Financial Report, Biotechnology and Healthcare, EPS
Company Name: Wuding Bio-Tech Co., Ltd.
Industry: Biotechnology and Healthcare
Year/Quarter: 2026 Q1
Basic Earnings Per Share: 0.81 Yuan
Operating Revenue: 520 million
Net Profit After Tax: 81 million
Keywords: Financial Report, Biotechnology and Healthcare, EPS